The United States announced the approval of listing of Influenza A H1N1 influenza vaccine

U.S. Federal Food and Drug Administration (FDA) 15 announced approval of Influenza A H1N1 influenza vaccine market. The U.S. government commissioned the production of 100 million 9 10 million vaccine is expected to be generally available next month, the nation’s requirements.
                                            
It is reported, FDA said that approved a total of four kinds of H1N1 influenza virus vaccines, respectively, by four companies successfully developed, can help protect individuals against severe disease and death threats. FDA said the experiment showed that adults after vaccination, about eight days to ten days can have a good preventive effect. As for how long a child can be made with the immune effects, has not yet been finalized. Some people are strongly allergic to eggs and may even have died, such people should avoid physical inoculated H1N1 new vaccines.

In addition, the United States President Barack Obama said his two daughters are prepared to vaccination, because the H1N1 attacks mainly targeted at young people.

Obama, in a television interview, said: “What is worrying is, H1N1 viruses and influenza viruses in general different, H1N1 attacks mainly targeted at young people.”

Give priority to influenza vaccine in the past are the elderly, but the invasion of a new influenza was mainly targeted at six months old to 24-year-olds, as well as pregnant women, so the U.S. health authorities made it clear that the priority vulnerable to infection for vaccination.

Share This

Related posts

• No related posts.